Actively Recruiting
Sacral Neuromodulation as Treatment for Fecal Incontinence
Led by McMaster University · Updated on 2022-04-05
20
Participants Needed
1
Research Sites
386 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to investigate if low level laser therapy will do more good than harm for patients with severe refractory fecal incontinence. It is a proof of concept study without a placebo arm.
CONDITIONS
Official Title
Sacral Neuromodulation as Treatment for Fecal Incontinence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with fecal incontinence
You will not qualify if you...
- Pregnant patients
- Known malignancies in the area of treatment
- Active bleeding in area of treatment
- Active deep vein thrombosis
- Presence of tattoos at area of treatment
- Patients who are light sensitive
- Patients who take steroids
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
McMaster University
Hamilton, Ontario, Canada, L8N3Z5
Actively Recruiting
Research Team
J
Jihong Chen, MD PhD
CONTACT
J
Jan D Huizinga, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here